Xiangshao granules can relieve emotional symptoms in menopausal women: a randomized controlled trial

References

• Bromberger JT, Kravitz HM. Mood and menopause: findings from the Study of Women's Health Across the Nation (SWAN) over 10 years. Obstet Gynecol Clin North Am 2011;38:609–25
   PubMed Web of Science ®Google Scholar
• Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:593–602
   PubMed Web of Science ®Google Scholar
• Bromberger JT, Kravitz HM, Chang YF, et al. Major depression during and after the menopausal transition: Study of Women's Health Across the Nation (SWAN). Psychol Med 2011;41:1879–88
   PubMed Web of Science ®Google Scholar
• Freeman EW, Sammel MD, Boorman DW, et al. Longitudinal pattern of depressive symptoms around natural menopause. JAMA Psychiatry 2014;71:36–43
   PubMed Web of Science ®Google Scholar
• Hepgul N, Cattaneo A, Zunszain PA, et al. Depression pathogenesis and treatment: what can we learn from blood mRNA expression? BMC Med 2013;11:28
   PubMed Web of Science ®Google Scholar
• Bromberger JT, Kravitz HM, Chang Y, et al. Does risk for anxiety increase during the menopausal transition? Study of Women's Health Across the Nation. Menopause 2013;20:488–95
   PubMed Web of Science ®Google Scholar
• Perez-Lopez FR, Chedraui P, Gilbert JJ, et al. Cardiovascular risk in menopausal women and prevalent related co-morbid conditions: facing the post-Women's Health Initiative era. Fertil Steril 2009;92:1171–86
   PubMed Web of Science ®Google Scholar
• Cizza G, Primma S, Csako G. Depression as a risk factor for osteoporosis. Trends Endocrinol Metab 2009;20:367–73
   PubMed Web of Science ®Google Scholar
• Zong Y, Tang Y, Xue Y, et al. Depression is associated with increased incidence of osteoporotic thoracolumbar fracture in postmenopausal women: a prospective study. Eur Spine J 2016;25:3418–23
   PubMed Web of Science ®Google Scholar
• Goldbacher EM, Bromberger J, Matthews KA. Lifetime history of major depression predicts the development of the metabolic syndrome in middle-aged women. Psychosom Med 2009;71:266–72
   PubMed Web of Science ®Google Scholar
• Maki PM, Kornstein SG, Joffe H, et al. Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations. Menopause 2018;25:1069–85
   PubMed Web of Science ®Google Scholar
• Tang R, Luo M, Li J, et al. Symptoms of anxiety and depression among Chinese women transitioning through menopause: findings from a prospective community-based cohort study. Fertil Steril 2019;112:1160–71
   PubMed Web of Science ®Google Scholar
• Chen Y, Liu J, Wu X, et al. Xiangshao granule exerts antidepressive effects in a depression mouse model by ameliorating deficits in hippocampal BDNF and TrkB. Evidence-Based Complementary and Alternative Medicine: eCAM 2013;2013:1–6
   Web of Science ®Google Scholar
• Yu Q. Traditional Chinese medicine: perspectives on and treatment of menopausal symptoms. Climacteric 2018;21:93–5
   PubMed Web of Science ®Google Scholar
• Wang FR, Xue L, Zhang HY. Effects of Xiangshao granule on mRNA and protein expression of mu opioid receptor in perimenstrual syndrome gan-qi invasion rats. Zhongguo Zhong Xi Yi Jie He Za Zhi 2012;32:1275–9
   PubMedGoogle Scholar
• Harlow SD, Gass M, Hall JE, et al. Executive summary of the stages of reproductive aging workshop +10: addressing the unfinished agenda of staging reproductive aging. Climacteric 2012;15:105–14
   PubMed Web of Science ®Google Scholar
• Zheng Y, Zhao J, Phillips M, et al. Validity and reliability of the Chinese Hamilton Depression Rating Scale. Br J Psychiatry 1988;152:660–4
   PubMed Web of Science ®Google Scholar
• Zimmerman M, Martinez JH, Young D, et al. Severity classification on the Hamilton Depression Rating Scale. J Affect Disord 2013;150:384–8
   PubMed Web of Science ®Google Scholar
• Bai R, Liu S, Zhao Y, et al. Depressive and anxiety disorders in systemic lupus erythematosus patients without major neuropsychiatric manifestations. J Immunol Res 2016;2016:2829018
   PubMed Web of Science ®Google Scholar
• Freeman EW, Sammel MD. Anxiety as a risk factor for menopausal hot flashes: evidence from the Penn Ovarian Aging cohort. Menopause 2016;23:942–9
   PubMed Web of Science ®Google Scholar
• Chung HF, Pandeya N, Dobson AJ, et al. The role of sleep difficulties in the vasomotor menopausal symptoms and depressed mood relationships: an international pooled analysis of eight studies in the InterLACE consortium. Psychol Med 2018;48:2550–61
   PubMed Web of Science ®Google Scholar
• Soares CN, Frey BN. Challenges and opportunities to manage depression during the menopausal transition and beyond. Psychiatr Clin North Am 2010;33:295–308
   PubMed Web of Science ®Google Scholar
• Klaiber EL, Broverman DM, Vogel W, et al. Individual differences in changes in mood and platelet monoamine oxidase (MAO) activity during hormonal replacement therapy in menopausal women. Psychoneuroendocrinology 1996;21:575–92
   PubMed Web of Science ®Google Scholar
• Siegel AM, Mathews SB. Diagnosis and treatment of anxiety in the aging woman. Curr Psychiatry Rep 2015;17:93
   PubMed Web of Science ®Google Scholar
• Hantsoo L, Epperson CN. Anxiety disorders among women: a female lifespan approach. Focus (Am Psychiatr Publ) 2017;15:162–72
   PubMedGoogle Scholar
• Rubinow DR, Johnson SL, Schmidt PJ, et al. Efficacy of estradiol in perimenopausal depression: so much promise and so few answers. Depress Anxiety 2015;32:539–49
   PubMed Web of Science ®Google Scholar
• Di YM, Yang L, Shergis JL, et al. Clinical evidence of Chinese medicine therapies for depression in women during perimenopause and menopause. Complement Ther Med 2019;47:102071
   PubMed Web of Science ®Google Scholar
• Wang X. The effects of Jingqianping Granules on serum neurotransmitter levels in patients with premenstrual syndrome with liver Qi invasion. J Liaoning University Tradit Chin Med 2012;14:45–7
   Google Scholar
• Li J, Zhou Y, Liu B-B, et al. Nobiletin ameliorates the deficits in hippocampal BDNF, TrkB, and synapsin I induced by chronic unpredictable mild stress. Evid Based Complement Alternat Med 2013;2013:359682
   PubMed Web of Science ®Google Scholar
• Martinotti G, Pettorruso M, De Berardis D, et al. Agomelatine increases BDNF serum levels in depressed patients in correlation with the improvement of depressive symptoms. IJNPPY 2016;19:pyw003
   Google Scholar
• Gong M-J, Han B, Wang S-m, et al. Icariin reverses corticosterone-induced depression-like behavior, decrease in hippocampal brain-derived neurotrophic factor (BDNF) and metabolic network disturbances revealed by NMR-based metabonomics in rats. J Pharm Biomed Anal 2016;123:63–73
   PubMed Web of Science ®Google Scholar
• Mandolini GM, Lazzaretti M, Delvecchio G, et al. Association between serum BDNF levels and maternal perinatal depression: a review. J Affect Disord 2020;261:271–6
   PubMed Web of Science ®Google Scholar
• Jichao S, Xinmin H, Xianguo R, et al. Saikosaponin A alleviates symptoms of attention deficit hyperactivity disorder through downregulation of DAT and enhancing BDNF expression in spontaneous hypertensive rats. Evid Based Complement Alternat Med 2017;2017:2695903
   PubMed Web of Science ®Google Scholar
• Chen X-Q, Chen S-J, Liang W-N, et al. Saikosaponin A attenuates perimenopausal depression-like symptoms by chronic unpredictable mild stress. Neurosci Lett 2018;662:283–9
   PubMed Web of Science ®Google Scholar
• El Khoudary SR, Greendale G, Crawford SL, et al. The menopause transition and women's health at midlife: a progress report from the Study of Women's Health Across the Nation (SWAN). Menopause 2019;26:1213–27
   PubMed Web of Science ®Google Scholar